(Q42449940)

31 October 2017

title

Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages (English)

1 reference

31 October 2017

1 reference

Pamela Fischer-Posovszky

object named as

Pamela Fischer-Posovszky

4

0 references

Martin Wabitsch

3

object named as

Martin Wabitsch

1 reference

31 October 2017

Paska A Permana

1

1 reference

31 October 2017

Weiyang Zhang

2

1 reference

31 October 2017

William C Duckworth

5

1 reference

31 October 2017

Peter D Reaven

6

1 reference

31 October 2017

publication date

24 February 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

31 October 2017

published in

1 reference

31 October 2017

volume

296

1 reference

31 October 2017

issue

5

1 reference

31 October 2017

page(s)

E1076-84

1 reference

Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Pioglitazone induces apoptosis of macrophages in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Chemokines control fat accumulation and leptin secretion by cultured human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Gene expression profiling of adipose tissue: individual, depot-dependent, and sex-dependent variabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Molecular recognition of nitrated fatty acids by PPARγ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Macrophage-secreted factors induce adipocyte inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Targets for TNF-alpha-induced lipolysis in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

Effects of Chronic Rosiglitazone Therapy on Gene Expression in Human Adipose Tissuein Vivoin Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.91013.2008

10.1152/AJPENDO.91013.2008

21 January 2018

Identifiers

DOI

1 reference

31 October 2017

1 reference